Vacunación antipoliomielítica en niños de la Ciudad de Buenos Aires

Magariños, Mirta; Curti, Paola; Marcos, Alejandra; Troisi, Estela; Saia, Mariana; Arnedo, Sofía; Califano, Gloria.
Arch. argent. pediatr ; 108(1): 71-74, feb. 2010. tab
Artículo en Español | BINACIS | ID: bin-125802

Documentos relacionados

  1. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
  2. Adverse events following immunization with bivalent oral poliovirus vaccine in Jiangsu, China.
  3. Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial.
  4. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
  5. Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial.
  6. Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine: a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 months.
  7. Novel Oral Polio Vaccine Safely Induces Antibodies Among Vaccine-Naive Infants.
  8. [Observation on safety of sequential vaccination schedule of different strain inactivated poliovirus vaccines].
  9. Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
  10. A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania.